HIMS

NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Dollar change -0.05
Percentage change -0.18	%

Peers: ELF LFMD PRGO TDOC GDRX AMWL DOCS CLOV RXRX TWST

| Held by: IJH VTI IWM VB VXF VBK IWO MDY IJK VTWO

Scroll to Statements

Index	RUT	P/E	52.52	EPS (ttm)	0.53	Insider Own	18.04%	Shs Outstand	212.46M	Perf Week	3.16%
Market Cap	6.24B	Forward P/E	31.80	EPS next Y	0.88	Insider Trans	-6.35%	Shs Float	182.08M	Perf Month	-15.80%
Income	126.04M	PEG	1.63	EPS next Q	0.12	Inst Own	74.05%	Short Float	33.32%	Perf Quarter	-9.01%
Sales	1.48B	P/S	4.23	EPS this Y	14.37%	Inst Trans	19.08%	Short Ratio	2.39	Perf Half Y	19.08%
Book/sh	2.16	P/B	13.01	EPS next Y	45.72%	ROA	21.62%	Short Interest	60.66M	Perf Year	127.82%
Cash/sh	1.35	P/C	20.78	EPS next 5Y	32.17%	ROE	30.71%	52W Range	11.20 - 72.98	Perf YTD	16.17%
Dividend Est.	-	P/FCF	31.47	EPS past 5Y	17.22%	ROI	25.92%	52W High	-61.51%	Beta	1.87
Dividend TTM	-	Quick Ratio	1.50	Sales past 5Y	62.28%	Gross Margin	70.39%	52W Low	150.80%	ATR (14)	3.08
Dividend Ex-Date	-	Current Ratio	1.79	EPS Y/Y TTM	614.50%	Oper. Margin	4.61%	RSI (14)	45.97	Volatility	6.88% 10.37%
Employees	1637	Debt/Eq	0.02	Sales Y/Y TTM	69.33%	Profit Margin	8.54%	Recom	2.44	Target Price	46.47
Option/Short	Yes / Yes	LT Debt/Eq	0.02	EPS Q/Q	1830.36%	Payout	0.00%	Rel Volume	0.54	Prev Close	28.14
Sales Surprise	2.18%	EPS Surprise	1.57%	Sales Q/Q	95.09%	Earnings	May 05 AMC	Avg Volume	25.34M	Price	28.09
SMA20	0.61%	SMA50	-22.32%	SMA200	5.31%	Trades		Volume	13,691,378	Change	-0.18%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-18-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$42 → $60
Jan-10-25	Downgrade	Citigroup	Neutral → Sell	$24 → $25
Jan-07-25	Initiated	BTIG Research	Buy	$35
Dec-17-24	Initiated	Morgan Stanley	Overweight	$42
Nov-14-24	Downgrade	BofA Securities	Buy → Underperform
Aug-22-24	Initiated	Needham	Buy	$24
Aug-09-24	Downgrade	Imperial Capital	Outperform → In-line
May-22-24	Downgrade	Citigroup	Buy → Neutral	$16 → $20
Apr-16-24	Downgrade	Jefferies	Buy → Hold	$17 → $15
Apr-10-24	Initiated	Canaccord Genuity	Buy	$20
Feb-28-24	Upgrade	Imperial Capital	In-line → Outperform	$16
Feb-26-24	Initiated	Leerink Partners	Market Perform	$10
Dec-07-23	Initiated	Imperial Capital	In-line	$9
Jul-28-23	Initiated	TD Cowen	Outperform	$11
Apr-11-23	Initiated	Robert W. Baird	Neutral	$10
Feb-09-23	Upgrade	Jefferies	Hold → Buy	$7 → $11
Nov-08-22	Upgrade	SVB Leerink	Mkt Perform → Outperform	$5
Nov-08-22	Upgrade	BofA Securities	Neutral → Buy	$7.50 → $8.50
Oct-17-22	Downgrade	Piper Sandler	Overweight → Neutral	$8 → $6
Sep-07-22	Initiated	Truist	Hold	$7

Show Previous Ratings

Apr-25-25 05:45PM	Hims & Hers Health, Inc. (HIMS) Stock Drops Despite Market Gains: Important Facts to Note (Zacks)
02:45PM	Novo Nordisk wins case to kick knockoff Ozempic off the market, but it may not last (Yahoo Finance)
Apr-24-25 11:39AM	EPD Growth in Emerging Market Supports Abbott Stock Amid Macro Woes (Zacks) +5.35%
Apr-23-25 11:21AM	Hims & Hers: Look Past Near-Term GLP-1 Risks, This Is A Great Dip To Buy (Seeking Alpha) +5.36%
07:38AM	BUZZ Investing: Tariff Chaos Shakes U.S. Equities (Seeking Alpha)
05:04AM	Loading…
05:04AM	2 Reasons to Like HIMS and 1 to Stay Skeptical (StockStory)
Apr-22-25 09:00AM	Is Most-Watched Stock Hims & Hers Health, Inc. (HIMS) Worth Betting on Now? (Zacks)
08:39AM	Zacks Industry Outlook Highlights Veeva Systems, Hims & Hers Health and Butterfly Network (Zacks)
08:13AM	Zimmer Biomet to Report Q1 Earnings: Here's What to Expect (Zacks)
07:29AM	Is it Apt to Retain Omnicell Stock in Your Portfolio Now? (Zacks)
Apr-21-25 05:32PM	Is Hims & Hers Health, Inc. (HIMS) the Best Telehealth Stock to Buy Now? (Insider Monkey) -5.10%
12:35PM	Hims & Hers: Top Pick For The Next Decade (Seeking Alpha)
09:57AM	Will Robust Exome and Genome Growth Boost WGS' Q1 Earnings Results? (Zacks)
08:44AM	Hims & Hers Health and AST SpaceMobile have been highlighted as Zacks Bull and Bear of the Day (Zacks)
08:34AM	IDXX Gears Up for Q1 Earnings: What to Expect From the Stock? (Zacks)
05:38AM	Loading…
05:38AM	3 Medical Info Systems Stocks to Ride the AI Wave in Trump Tariff Era (Zacks)
Apr-19-25 07:00AM	Oddity: Rare Beauty Gem (Seeking Alpha)
Apr-18-25 05:20AM	Bull of the Day: Hims & Hers Health (HIMS) (Zacks)
Apr-17-25 05:45PM	Hims & Hers Health, Inc. (HIMS) Surpasses Market Returns: Some Facts Worth Knowing (Zacks) -5.10%
12:46PM	Why Eli Lilly Stock Is Soaring Today, While Novo Nordisk and Viking Therapeutics Slide (Motley Fool)
10:18AM	Eli Lilly stock soars on positive weight-loss pill results (Yahoo Finance Video)
09:52AM	3 Undervalued Medical Device Stocks to Buy in 2025 Amid Tariff Woes (Zacks)
09:35AM	Lilly Soars After Weight-Loss Pill Results Rival Ozempics (Bloomberg)
09:12AM	Should You Continue to Hold Veracyte Stock in Your Portfolio? (Zacks)
09:00AM	Reasons to Hold TNDM Stock in Your Portfolio for Now (Zacks)
08:53AM	ALGN Gears Up for Q1 Earnings: What Lies Ahead for the Stock? (Zacks)
08:31AM	Solid TMTT Growth to Drive Edwards Lifesciences' Q1 Earnings (Zacks)
05:03AM	Healthcare Technology Stocks Q4 In Review: Hims & Hers Health (NYSE:HIMS) Vs Peers (StockStory)
Apr-16-25 11:51PM	Why Hims & Hers Health, Inc. (HIMS) Declined on Wednesday (Insider Monkey) -8.52%
04:00PM	Hims & Hers Health, Inc. (HIMS): A Bull Case Theory (Insider Monkey)
01:15PM	Loading…
01:15PM	Will a Strong MA Business Aid Elevance Health's Q1 Earnings? (Zacks)
10:21AM	Is it the Right Time to Hold STERIS Stock in Your Portfolio? (Zacks)
10:17AM	Labcorp Q1 Earnings Preview: Diagnostics Arm Likely to Drive Growth (Zacks)
08:43AM	Hims & Hers Stock Gains 5.8% in 3 Months: Here's How to Play it (Zacks)
06:20AM	Is First Trust Mid Cap Core AlphaDEX ETF (FNX) a Strong ETF Right Now? (Zacks)
Apr-15-25 09:40AM	Why This 1 Value Stock Could Be a Great Addition to Your Portfolio (Zacks)
Apr-14-25 04:05PM	Hims & Hers to Announce First Quarter 2025 Financial Results on May 5, 2025 (Business Wire)
06:20AM	Should First Trust Mid Cap Core AlphaDEX ETF (FNX) Be on Your Investing Radar? (Zacks)
Apr-11-25 05:45PM	Hims & Hers Health, Inc. (HIMS) Rises But Trails Market: What Investors Should Know (Zacks)
Apr-10-25 08:29AM	Here's Cedar Grove Capital Management's Take Away from Its Short Position Hims and Hers Health (HIMS) (Insider Monkey) -9.09%
08:00AM	Hims' Weight Loss Expansion: Real Growth or Just Hype? (MarketBeat)
Apr-08-25 01:47PM	Wall Street Lunch: Musk's Reported Plea To Reverse Tariffs Falls Flat (Seeking Alpha) -6.01%
10:06AM	Here's Why Hims & Hers Health (HIMS) is Growing Revenue And Profitability (Insider Monkey)
09:46AM	Bruker Announces Groundbreaking 1.3 GHz NMR System, Stock Up (Zacks)
06:20AM	Is Invesco S&P SmallCap Quality ETF (XSHQ) a Strong ETF Right Now? (Zacks)
Apr-07-25 09:00AM	Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know (Zacks) +6.85%
08:00AM	ClearBridge Small Cap Growth Strategy Q1 2025 Commentary (Seeking Alpha)
Apr-05-25 11:00AM	Markets Watch Out For Core CPI With Big Banks Set To Report Earnings (Seeking Alpha)
Apr-04-25 06:51AM	Thermo Fisher Stock Benefits From the Launch of Krios 5 Cryo-TEM (Zacks) -7.15%
Apr-03-25 01:51PM	Eli Lilly Vs. Hims & Hers In DTC Weight Loss Market? - There Is Only One Winner (Seeking Alpha) -10.35%
10:08AM	Analysts Stay Cautious on HIMS Stock amid Core Business Uncertainty (TipRanks)
09:21AM	Bruker Introduces Breakthrough d-DNP Polarizer: Stock to Gain? (Zacks)
09:00AM	Should You Continue to Hold Bio-Rad Stock in Your Portfolio? (Zacks)
Apr-02-25 06:18PM	Why Hims & Hers Health Stock Couldn't Beat the Market Today (Motley Fool)
04:32PM	Hims Dives After Its Lilly-Rivaling Obesity Plan Faces An Unexpected Hitch (Investor's Business Daily)
04:32PM	Hims Claws Back After Its Lilly-Rivaling Obesity Plan Faces An Unexpected Hitch (Investor's Business Daily)
02:00PM	3 Stocks to Buy for "Liberation" From Trump Tariffs & Recession Woes (Zacks)
11:03AM	Wall Street Lunch: Tesla 'Fork In The Road Moment' (Seeking Alpha)
09:45AM	LH Stock to Gain From Launch of HPV and STI Self-Collection Options (Zacks)
09:02AM	Hims & Hers Health, Inc. (HIMS): A Bull Case Theory (Insider Monkey)
06:20AM	Should SPDR S&P 600 Small Cap Growth ETF (SLYG) Be on Your Investing Radar? (Zacks)
06:20AM	Should First Trust Mid Cap Growth AlphaDEX ETF (FNY) Be on Your Investing Radar? (Zacks)
04:26AM	Company News for Apr 2, 2025 (Zacks)
Apr-01-25 08:00PM	Who Should Pay for Ozempic Is the Next Big Workplace Fight (The Wall Street Journal) +5.08%
07:38PM	Hims & Hers Expands Weight Loss Offering, Adds Lillys Zepbound to Platform (The Wall Street Journal)
05:38PM	Hims & Hers Stock Surges as Telehealth Platform Adds Eli Lilly Weight-Loss Drugs (Investopedia)
04:48PM	Hims & Hers adds Eli Lilly GLP-1 drugs, Johnson & Johnson setback (Yahoo Finance Video)
04:15PM	Why Hims & Hers Health Stock Soared Tuesday (Motley Fool)
04:15PM	Hims Stock Jumps After Adding Eli Lilly's Obesity Drug To Its Platform (Investor's Business Daily)
04:02PM	Hims Stock Jumps After Inking Deal To Sell Eli Lilly's Obesity Drug, Zepbound (Investor's Business Daily)
03:40PM	Hims & Hers Health (HIMS) Stock Trades Up, Here Is Why (StockStory)
02:30PM	Hims Stock Rockets After Inking Deal To Sell Eli Lilly's Obesity Drug, Zepbound (Investor's Business Daily)
11:04AM	Nebius: I'm Betting Against Jim Cramer (Seeking Alpha)
08:27AM	ABT Stock to Gain From Early CE Mark Approval of Volt PFA System (Zacks)
08:24AM	Is This the Right Time to Hold ALGN Stock in Your Portfolio? (Zacks)
08:15AM	2 Healthcare Stocks to Watch as JPMorgan Boosts Gilead Rating (MarketBeat)
06:20AM	Should Invesco S&P SmallCap Quality ETF (XSHQ) Be on Your Investing Radar? (Zacks)
Mar-31-25 05:45PM	Hims & Hers Health, Inc. (HIMS) Surpasses Market Returns: Some Facts Worth Knowing (Zacks)
Mar-28-25 09:30AM	Thermo Fisher's New Deal With CZ Imaging Institute May Boost Its Stock (Zacks) -8.71%
04:55AM	Is Hims & Hers Health Stock a Smart Buy After Plunging More Than 50%? (Motley Fool)
Mar-27-25 12:01PM	International Expansion, Product Launches Support BSX Stock (Zacks)
08:08AM	Is Quest Diagnostics Stock Worth Holding Onto Right Now? (Zacks)
07:14AM	National Vision Stock Rises 28.2% YTD: Will the Rally Continue? (Zacks)
03:54AM	Why Hims & Hers Health Inc. (HIMS) Crashed On Wednesday? (InsiderMonkey)
Mar-26-25 11:30AM	Hims & Hers Health (HIMS) Down 7.1% Since Last Earnings Report: Can It Rebound? (Zacks) -9.94%
09:15AM	Hims & Hers Health: Reaching Escape Velocity Goes Unnoticed By The Market (SeekingAlpha)
08:31AM	Is This the Right Time to Hold Integra Stock in Your Portfolio? (Zacks)
Mar-25-25 05:45PM	Hims & Hers Health, Inc. (HIMS) Stock Declines While Market Improves: Some Information for Investors (Zacks)
09:21AM	Why Hims & Hers Health Inc (HIMS) Is Surging In 2025? (InsiderMonkey)
09:16AM	ABT Stock to Gain From FDA IDE Approval for Its Coronary IVL System (Zacks)
09:00AM	Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
06:11AM	The Case For Hims & Hers: Diversification And Growth Beyond Semaglutide (SeekingAlpha)
Mar-24-25 12:44PM	Why Novo Nordisk Stock Dropped on Monday, but Eli Lilly and Him & Hers Health Popped (Motley Fool) +7.65%
11:47AM	Illumina's AGD Project Completes 250,000 Whole Genomes: Stock to Gain? (Zacks)
11:37AM	New Thrombectomy Product Launches Support PEN Stock Amid Macro Issues (Zacks)
08:01AM	Hims & Hers Health (HIMS) Moves 5.7% Higher: Will This Strength Last? (Zacks)
Mar-22-25 03:20AM	BUZZ Investing: Fed's Glimmer Of Hope Amid Market Corrections (SeekingAlpha)
03:16AM	Why Hims & Hers Health Inc. (HIMS) Went Up On Friday? (InsiderMonkey)
Mar-21-25 08:22AM	GMED Stock Jumps 41.8% in a Year: What's Behind the Rally? (Zacks) +5.72%
Mar-20-25 04:38PM	Hims & Hers Health: Developing A Better Understanding (SeekingAlpha)

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Baird Melissa	Chief Operating Officer	Apr 21 '25	Option Exercise	1.97	33,333	65,653	838,416	Apr 23 04:21 PM
Baird Melissa	Chief Operating Officer	Apr 21 '25	Sale	25.78	33,333	859,256	805,083	Apr 23 04:21 PM
Becklund Irene	PAO	Apr 22 '25	Sale	26.49	2,936	77,775	5,071	Apr 23 04:21 PM
Becklund Irene	Officer	Apr 22 '25	Proposed Sale	26.49	2,936	77,775		Apr 22 09:46 AM
Melissa Baird	Officer	Apr 21 '25	Proposed Sale	25.84	33,333	861,325		Apr 21 04:37 PM
Dudum Andrew	Chief Executive Officer	Apr 16 '25	Option Exercise	2.43	33,668	81,813	128,563	Apr 18 03:40 PM
Dudum Andrew	Chief Executive Officer	Apr 16 '25	Sale	28.23	47,534	1,342,094	332,728	Apr 18 03:40 PM
Dudum Andrew	Chief Executive Officer	Apr 16 '25	Sale	28.04	36,460	1,022,453	92,103	Apr 18 03:40 PM
Boughton Soleil	Chief Legal Officer	Mar 03 '25	Sale	45.14	4,151	187,376	166,134	Apr 16 04:30 PM
Boughton Soleil	Chief Legal Officer	Apr 14 '25	Sale	28.72	3,236	92,938	162,898	Apr 16 04:30 PM
Okupe Oluyemi	Chief Financial Officer	Apr 15 '25	Option Exercise	6.43	6,437	41,377	130,541	Apr 16 04:30 PM
Okupe Oluyemi	Chief Financial Officer	Apr 15 '25	Sale	28.50	11,581	330,082	118,960	Apr 16 04:30 PM
Dudum Andrew	Officer	Apr 16 '25	Proposed Sale	28.15	83,994	2,364,547		Apr 16 10:44 AM
Boughton Soleil	Officer	Apr 14 '25	Proposed Sale	28.72	3,236	92,938		Apr 14 09:52 AM
Baird Melissa	Chief Operating Officer	Apr 09 '25	Option Exercise	1.75	33,337	58,340	838,420	Apr 10 04:30 PM
Baird Melissa	Chief Operating Officer	Apr 09 '25	Sale	27.32	33,337	910,687	805,083	Apr 10 04:30 PM
Melissa Baird	Officer	Apr 09 '25	Proposed Sale	29.49	33,337	983,108		Apr 09 04:42 PM
Baird Melissa	Chief Operating Officer	Apr 04 '25	Option Exercise	5.01	40,380	202,304	805,083	Apr 07 04:15 PM
Becklund Irene	PAO	Apr 03 '25	Sale	28.78	2,203	63,402	8,007	Apr 04 04:52 PM
Okupe Oluyemi	Chief Financial Officer	Apr 02 '25	Option Exercise	5.01	6,437	32,249	135,685	Apr 04 04:52 PM
Okupe Oluyemi	Chief Financial Officer	Apr 02 '25	Sale	29.26	11,581	338,833	124,104	Apr 04 04:52 PM
Becklund Irene	Officer	Apr 03 '25	Proposed Sale	28.78	2,203	63,402		Apr 03 10:29 AM
Baird Melissa	Chief Operating Officer	Mar 31 '25	Option Exercise	5.01	13,460	67,435	764,703	Apr 01 04:57 PM
Boughton Soleil	Chief Legal Officer	Mar 31 '25	Sale	27.77	3,236	89,864	170,285	Apr 01 04:57 PM
Boughton Soleil	Officer	Mar 31 '25	Proposed Sale	27.77	3,236	89,864		Mar 31 09:54 AM
Baird Melissa	Chief Operating Officer	Mar 26 '25	Option Exercise	0.40	67,687	27,075	818,930	Mar 27 05:04 PM
Baird Melissa	Chief Operating Officer	Mar 26 '25	Sale	34.84	67,687	2,358,145	751,243	Mar 27 05:04 PM
Melissa Baird	Officer	Mar 26 '25	Proposed Sale	33.36	67,687	2,258,038		Mar 26 04:09 PM
Okupe Oluyemi	Chief Financial Officer	Mar 21 '25	Sale	32.41	23,118	749,176	129,248	Mar 24 04:35 PM
Oluyemi Okupe	Officer	Mar 21 '25	Proposed Sale	34.75	69,442	2,413,110		Mar 21 05:00 PM
Carroll Patrick Harrison	Chief Medical Officer	Mar 18 '25	Sale	34.31	23,287	798,977	209,661	Mar 18 06:35 PM
Dudum Andrew	Chief Executive Officer	Mar 17 '25	Option Exercise	2.43	125,335	304,564	226,447	Mar 18 06:35 PM
Dudum Andrew	Chief Executive Officer	Mar 17 '25	Sale	33.98	128,127	4,353,124	173,655	Mar 18 06:35 PM
Dudum Andrew	Chief Executive Officer	Mar 18 '25	Sale	33.85	78,760	2,666,199	94,895	Mar 18 06:35 PM
Dudum Andrew	Chief Executive Officer	Mar 17 '25	Sale	33.64	47,534	1,599,170	380,262	Mar 18 06:35 PM
Boughton Soleil	Chief Legal Officer	Mar 18 '25	Sale	34.31	3,236	111,027	173,521	Mar 18 06:35 PM
Becklund Irene	PAO	Mar 18 '25	Sale	34.31	8,277	283,984	10,210	Mar 18 06:34 PM
Dudum Andrew	Officer	Mar 18 '25	Proposed Sale	33.85	78,760	2,666,200		Mar 18 12:24 PM
Boughton Soleil	Officer	Mar 18 '25	Proposed Sale	34.31	3,236	111,027		Mar 18 10:56 AM
Carroll Patrick Harrison	Officer	Mar 18 '25	Proposed Sale	34.31	23,287	798,977		Mar 18 10:52 AM
Becklund Irene	Officer	Mar 18 '25	Proposed Sale	34.31	8,277	283,984		Mar 18 10:24 AM
Dudum Andrew	Officer	Mar 17 '25	Proposed Sale	33.89	175,661	5,952,296		Mar 17 03:26 PM
Becklund Irene	PAO	Mar 11 '25	Sale	34.77	2,203	76,598	2,203	Mar 13 04:31 PM
Becklund Irene	Officer	Mar 11 '25	Proposed Sale	34.77	2,203	76,598		Mar 11 10:03 AM
Becklund Irene	PAO	Mar 03 '25	Sale	45.14	2,913	131,493	4,406	Mar 05 04:42 PM
Pendarvis Christiane	Director	Mar 05 '25	Proposed Sale	40.00	12,500	500,000		Mar 05 11:40 AM
Becklund Irene	Officer	Mar 03 '25	Proposed Sale	45.14	2,913	131,493		Mar 03 11:59 AM
Boughton Soleil	Officer	Mar 03 '25	Proposed Sale	45.14	4,151	187,376		Mar 03 11:45 AM
Chi Michael	Chief Commercial Officer	Feb 24 '25	Option Exercise	5.01	17,303	86,688	210,904	Feb 25 04:38 PM
Chi Michael	Chief Commercial Officer	Feb 24 '25	Sale	48.14	17,303	832,966	193,601	Feb 25 04:38 PM
Chi Michael	Officer	Feb 24 '25	Proposed Sale	48.14	17,303	832,966		Feb 24 10:46 AM
Dudum Andrew	Chief Executive Officer	Feb 18 '25	Option Exercise	2.43	125,335	304,564	223,022	Feb 20 08:18 PM
Dudum Andrew	Chief Executive Officer	Feb 18 '25	Sale	58.27	128,127	7,466,121	97,687	Feb 20 08:18 PM
Dudum Andrew	Chief Executive Officer	Feb 18 '25	Sale	58.15	47,534	2,763,942	427,796	Feb 20 08:18 PM
Boughton Soleil	Chief Legal Officer	Feb 18 '25	Sale	60.69	4,152	251,985	157,345	Feb 20 08:17 PM
Chi Michael	Chief Commercial Officer	Feb 19 '25	Option Exercise	13.90	7,500	104,250	201,101	Feb 20 08:17 PM
Chi Michael	Chief Commercial Officer	Feb 19 '25	Sale	59.26	7,500	444,450	193,601	Feb 20 08:17 PM
Chi Michael	Officer	Feb 19 '25	Proposed Sale	59.26	7,500	444,450		Feb 19 10:16 AM
Boughton Soleil	Officer	Feb 18 '25	Proposed Sale	60.69	4,152	251,985		Feb 18 11:22 AM
Dudum Andrew	Officer	Feb 18 '25	Proposed Sale	58.24	175,661	10,230,058		Feb 18 11:10 AM
Baird Melissa	Chief Operating Officer	Feb 12 '25	Option Exercise	0.40	67,687	27,075	774,559	Feb 14 04:49 PM
Baird Melissa	Chief Operating Officer	Feb 12 '25	Sale	44.71	67,687	3,026,624	706,872	Feb 14 04:49 PM
Melissa Baird	Officer	Feb 12 '25	Proposed Sale	46.34	67,687	3,136,616		Feb 12 04:36 PM
Chi Michael	Chief Commercial Officer	Feb 10 '25	Option Exercise	6.82	7,259	49,506	200,860	Feb 11 04:16 PM
Chi Michael	Chief Commercial Officer	Feb 10 '25	Sale	43.28	7,259	314,170	193,601	Feb 11 04:16 PM
Okupe Oluyemi	Chief Financial Officer	Feb 10 '25	Option Exercise	5.01	6,437	32,249	119,370	Feb 11 04:16 PM
Okupe Oluyemi	Chief Financial Officer	Feb 10 '25	Sale	43.01	11,581	498,100	107,789	Feb 11 04:16 PM
Chi Michael	Officer	Feb 10 '25	Proposed Sale	43.28	7,259	314,170		Feb 10 12:09 PM
Okupe Oluyemi	Chief Financial Officer	Feb 04 '25	Option Exercise	5.01	6,437	32,249	124,514	Feb 05 04:31 PM
Okupe Oluyemi	Chief Financial Officer	Feb 04 '25	Sale	38.92	11,581	450,730	112,933	Feb 05 04:31 PM
Dudum Andrew	Chief Executive Officer	Jan 31 '25	Option Exercise	2.43	100,000	243,000	127,918	Feb 04 04:26 PM
Dudum Andrew	Chief Executive Officer	Jan 31 '25	Sale	35.22	100,000	3,522,300	27,918	Feb 04 04:26 PM
Boughton Soleil	Chief Legal Officer	Feb 03 '25	Sale	35.30	4,153	146,601	161,497	Feb 04 04:25 PM
Chi Michael	Chief Commercial Officer	Feb 03 '25	Option Exercise	11.53	2,054	23,683	195,655	Feb 04 04:25 PM
Chi Michael	Chief Commercial Officer	Feb 03 '25	Sale	35.30	2,054	72,506	193,601	Feb 04 04:25 PM
Boughton Soleil	Officer	Feb 03 '25	Proposed Sale	35.30	4,153	146,601		Feb 03 11:11 AM
Chi Michael	Officer	Feb 03 '25	Proposed Sale	35.30	2,054	72,506		Feb 03 11:11 AM
Dudum Andrew	Officer	Jan 31 '25	Proposed Sale	35.22	100,000	3,522,297		Jan 31 10:43 AM
Chi Michael	Chief Commercial Officer	Jan 24 '25	Option Exercise	5.01	17,304	86,693	210,905	Jan 24 05:20 PM
Chi Michael	Chief Commercial Officer	Jan 24 '25	Sale	31.00	17,304	536,424	193,601	Jan 24 05:20 PM
Dudum Andrew	Chief Executive Officer	Jan 23 '25	Option Exercise	2.43	27,098	65,848	55,016	Jan 24 05:20 PM
Dudum Andrew	Chief Executive Officer	Jan 23 '25	Sale	30.08	27,098	815,029	27,918	Jan 24 05:20 PM
Chi Michael	Officer	Jan 24 '25	Proposed Sale	31.00	17,304	536,424		Jan 24 09:53 AM
Boughton Soleil	Chief Legal Officer	Jan 21 '25	Option Exercise	5.01	50,000	250,500	219,803	Jan 23 04:32 PM
Boughton Soleil	Chief Legal Officer	Jan 21 '25	Sale	29.90	54,153	1,619,108	165,650	Jan 23 04:32 PM
Baird Melissa	Chief Operating Officer	Jan 21 '25	Option Exercise	0.40	67,687	27,075	774,559	Jan 23 04:32 PM
Baird Melissa	Chief Operating Officer	Jan 21 '25	Sale	29.35	67,687	1,986,731	706,872	Jan 23 04:32 PM
Chi Michael	Chief Commercial Officer	Jan 21 '25	Option Exercise	13.90	306	4,253	193,907	Jan 23 04:32 PM
Chi Michael	Chief Commercial Officer	Jan 21 '25	Sale	28.68	306	8,776	193,601	Jan 23 04:32 PM
Dudum Andrew	Chief Executive Officer	Jan 22 '25	Option Exercise	2.43	14,269	34,674	42,187	Jan 23 04:32 PM
Dudum Andrew	Chief Executive Officer	Jan 21 '25	Option Exercise	2.43	300	729	28,218	Jan 23 04:32 PM
Dudum Andrew	Chief Executive Officer	Jan 22 '25	Sale	30.08	14,269	429,184	27,918	Jan 23 04:32 PM
Dudum Andrew	Chief Executive Officer	Jan 21 '25	Sale	30.00	300	9,000	27,918	Jan 23 04:32 PM
Dudum Andrew	Officer	Jan 23 '25	Proposed Sale	30.08	27,098	815,030		Jan 23 12:55 PM
Dudum Andrew	Officer	Jan 22 '25	Proposed Sale	30.08	14,269	429,184		Jan 22 04:24 PM
Melissa Baird	Officer	Jan 21 '25	Proposed Sale	29.81	67,687	2,017,749		Jan 21 04:55 PM
Dudum Andrew	Officer	Jan 21 '25	Proposed Sale	30.00	300	9,000		Jan 21 04:54 PM
Boughton Soleil	Officer	Jan 21 '25	Proposed Sale	29.90	54,153	1,619,108		Jan 21 04:32 PM
Dudum Andrew	Chief Executive Officer	Jan 16 '25	Option Exercise	2.43	33,668	81,813	64,378	Jan 21 04:13 PM
Dudum Andrew	Chief Executive Officer	Jan 16 '25	Sale	27.01	47,534	1,283,884	475,330	Jan 21 04:13 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Hims & Hers Health Inc

Upgrade your FINVIZ experience